Crispr Therapeutics shares owned by Green Alpha Advisors
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Green Alpha Advisors
from 13F filings
Historical chart of Green Alpha Advisors investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Green Alpha Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Green Alpha Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $900k | 19k | 46.98 |
| 2024-06-30 | $1.1M | 20k | 54.01 |
| 2024-03-31 | $1.8M | 27k | 68.16 |
| 2023-12-31 | $1.5M | 25k | 62.60 |
| 2023-09-30 | $1.6M | 35k | 45.39 |
| 2023-06-30 | $1.9M | 34k | 56.14 |
| 2023-03-31 | $1.5M | 33k | 45.23 |
| 2022-12-31 | $1.2M | 31k | 40.66 |
| 2022-09-30 | $1.8M | 28k | 65.35 |
| 2022-06-30 | $14M | 228k | 60.77 |
| 2022-03-31 | $1.6M | 26k | 62.78 |
| 2021-12-31 | $1.3M | 17k | 75.76 |
| 2021-09-30 | $1.7M | 15k | 111.92 |
| 2021-06-30 | $2.1M | 13k | 161.87 |
| 2021-03-31 | $828k | 6.8k | 121.87 |
| 2020-12-31 | $973k | 6.4k | 153.18 |